What the SYNTAX Score Actually Measures

---

Coronary artery disease is not the same in every patient. One person has a single straightforward blockage in one artery, far from any branch points.

Another has three arteries all blocked in complex patterns, with calcification, bifurcations, and total occlusions. Treating them both with a stent is not the same decision.

The SYNTAX score captures this complexity. It is calculated by an interventional cardiologist or cardiac surgeon looking at your angiogram images and scoring the specific features of each blockage. The higher the score, the more complex the disease, and the less well stenting is likely to perform compared to bypass surgery.

SYNTAX stands for SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery. It came out of a large European trial in the late 2000s that compared stenting and bypass surgery across 1,800 patients and generated the scoring tool now used worldwide.

The core insight it formalized was something experienced cardiac surgeons had known for years: the more complex and diffuse the blockages, the worse stenting tends to do relative to bypass surgery. A stent opens one point in one artery.

Bypass creates new routes around multiple blockages simultaneously. For simple disease, a stent does fine. For complex disease, bypass wins on every long-term outcome that matters.

How It Is Calculated — The 12 Components

---

The SYNTAX score is calculated by analysing each coronary lesion — each blockage — against 12 specific features. Each feature adds points to the score.

A simple, short blockage in a small artery adds few points. A long, calcified, bifurcating blockage in the left anterior descending artery adds many more.

Feature scored	Why it matters for the bypass vs stent decision
Dominance of coronary circulation	Right-dominant, left-dominant, or co-dominant. Affects how much of the heart is at risk from each blockage.
Number of lesions	More lesions = higher score. Each blockage assessed individually.
Segment weighting	A blockage in the left main artery scores higher than the same blockage in a smaller vessel. Reflects how much heart muscle is at risk.
Total occlusion	Complete blockage (100%) scores significantly higher than partial. Stenting a total occlusion is technically much harder.
Trifurcation lesion	Blockage at a point where the artery splits into three. Much more complex to treat with a stent than bypass.
Bifurcation lesion	Blockage at a branch point. A stent in the main vessel risks blocking the branch. Bypass avoids this entirely.
Aorto-ostial lesion	Blockage at the very origin of a coronary artery. High restenosis risk after stenting.
Severe tortuosity	Extreme bends in the artery before the blockage. Makes catheter delivery of a stent technically very difficult.
Lesion length	Longer blockages need longer stents. The longer the stent, the higher the restenosis risk.
Severe calcification	Hard calcium deposits make balloon expansion difficult and stent deployment less predictable.
Thrombus	Blood clot in the artery increases the risk of stent-related complications significantly.
Diffuse disease / small vessels	Disease spread throughout a vessel rather than confined to one point. Bypass can route around the whole diseased segment. A stent cannot.

Each of these features adds points to an individual lesion score. The scores for all lesions in all three coronary arteries are summed to produce the total SYNTAX score. The maximum possible is theoretically 83, though scores above 50 are rare in clinical practice.

Your SYNTAX score should be in your angiogram report. If it is not explicitly stated, ask your cardiologist to calculate it.

It takes about 10 minutes for someone who knows how. If they decline to calculate it, that is worth noting.

What Your Score Means — Low, Intermediate, High

---

Score	Category	Recommendation	What the evidence shows
0 – 22	Low	Stenting reasonable	At 3 years and 5 years, stenting produces similar rates of death, heart attack, and stroke as bypass. Both are valid. Stenting offers faster recovery.
23 – 32	Intermediate	Individual assessment	At 5 years, bypass shows lower rates of repeat revascularisation. Death and heart attack rates similar. Anatomy, patient age, and fitness are decisive. Both a cardiologist and surgeon should advise.
≥ 33	High	Bypass strongly preferred	Stenting produces significantly higher rates of major adverse cardiac events at 1, 3, and 5 years. The ACC/AHA guidelines give bypass a Class I recommendation here. Stenting is a Class III — meaning harm may exceed benefit.

The Class III designation for stenting in high-SYNTAX disease is not a mild caution. Class III in ACC/AHA guidelines means the intervention may cause harm.

It is the strongest negative recommendation the guidelines issue. If you have a SYNTAX score above 33 and someone is recommending stenting without a detailed discussion of why bypass is not appropriate for you specifically — that conversation is worth having more carefully.

What the Original SYNTAX Trial Actually Showed

---

The SYNTAX trial enrolled 1,800 patients with three-vessel or left main coronary artery disease and randomised them to either bypass surgery or stenting with a paclitaxel-eluting stent. The results at one, three, and five years shaped every cardiac surgery guideline written since.

At one year, the overall outcomes were broadly similar. At three years, the stenting group had significantly higher rates of major adverse cardiac and cerebrovascular events. At five years, the gap widened further in patients with intermediate and high SYNTAX scores.

The specific findings that mattered most were about repeat revascularisation. Patients who received stents needed additional procedures — another stent, or eventually bypass surgery — at substantially higher rates than bypass patients. This is the finding that drives the guideline preference for bypass in complex disease: it does the job more completely the first time.

There is one honest limitation worth acknowledging. The stent used in the SYNTAX trial — the TAXUS paclitaxel-eluting stent — is older technology.

Modern drug-eluting stents perform better. Subsequent trials using newer-generation stents have shown somewhat improved outcomes for stenting, particularly in the intermediate SYNTAX range. The thresholds have not changed significantly in the current guidelines, but the intermediate zone is genuinely more contested now than it was in 2009.

When SYNTAX Score Is Not the Whole Story

---

The SYNTAX score is the most important number. It is not the only number. Three patient groups require additional considerations beyond what the score alone predicts.

Diabetics with multi-vessel disease

If you are diabetic and have blockages in two or three coronary arteries, the ACC/AHA guidelines give bypass surgery a Class I recommendation regardless of your SYNTAX score. This is not a marginal finding. It comes from the FREEDOM trial, which enrolled 1,900 diabetic patients with multi-vessel disease and found that bypass significantly reduced the rate of death and heart attack compared to stenting at five years.

The biological reason is understood. Diabetes damages small vessels diffusely — not just the focal blockages visible on an angiogram but the microscopic vessels downstream from them.

Bypass surgery creates new routes that bypass the entire diseased segment. A stent treats only what is visible on the angiogram. The invisible small-vessel disease continues to progress around the stent.

If you are diabetic, have multi-vessel disease, and someone is recommending stenting, ask specifically: "Given the FREEDOM trial findings and the ACC/AHA Class I recommendation for bypass in diabetic multi-vessel disease, why is stenting preferred for my case?"

Left main coronary artery disease

The left main coronary artery supplies roughly 75% of the left ventricle's blood supply. A blockage here is categorically different from a blockage in a smaller vessel — the territory at risk is enormous.

For left main disease with a SYNTAX score above 33, bypass is strongly preferred. For low-SYNTAX left main disease in a medically complex patient who cannot safely undergo surgery, stenting may be reasonable with an experienced interventional team. But this decision should never be made by a single cardiologist — it requires a formal heart team discussion.

Patients who cannot safely have surgery

If your cardiac surgeon, after reviewing your case, determines that the risk of open-heart surgery is prohibitive — because of severe lung disease, very poor heart function, or other factors — then stenting may be the best available option even in high-SYNTAX disease. A suboptimal revascularisation that you survive is better than the alternative.

This is the legitimate clinical reason for stenting in high-SYNTAX disease. It is not the reason being given when a high-SYNTAX patient sees only an interventional cardiologist and goes directly to a stent without a surgical opinion.

The Conflict of Interest Nobody Mentions

---

This section will make some cardiologists uncomfortable. It is included because omitting it would be dishonest, and the patient who does not know about it is the one who pays the price.

Interventional cardiologists — the physicians who place stents — are paid for placing stents. The more stents placed, the more revenue generated for both the physician and the hospital's catheterisation laboratory.

This is not a conspiracy. It is the straightforward financial structure of procedural medicine.

A cardiologist who places 300 stents a year and is employed by a hospital that profits from each cath lab case has a structural incentive to recommend stenting in borderline cases. This does not mean every interventional cardiologist overuses stents.

Most are honest physicians who follow the guidelines. But it is the reason that the ACC/AHA guidelines explicitly recommend that patients with multi-vessel coronary artery disease be evaluated by a formal heart team — not just an interventional cardiologist, but a cardiac surgeon as well — before a treatment decision is made.

If you have only seen an interventional cardiologist and been told you need stents — and you have multi-vessel disease or a SYNTAX score above 22 — ask to speak with a cardiac surgeon before you consent. You are entitled to that opinion. A physician who discourages a surgical consult in a patient with intermediate or high SYNTAX disease is not following the guidelines.

The Exact Questions to Ask Before You Decide

---

These are not general questions about "what are my options." They are specific questions that require specific answers — and the quality of the answers will tell you whether you are in the right hands.

1. 1

   "What is my SYNTAX score, and which category does it fall in?"

   If the cardiologist cannot give you this number, or does not know what it is, that tells you something important. The SYNTAX score has been the international standard for this decision since 2009. A cardiologist recommending multi-vessel revascularisation who cannot tell you the SYNTAX score is not following the guidelines.

2. 2

   "Has a cardiac surgeon reviewed my angiogram — and do I have access to their opinion?"

   For any patient with multi-vessel disease or left main disease, the guidelines require a heart team discussion. Ask whether this has happened. If the answer is no, request it before you consent to anything.

3. 3

   "If I choose stenting, what is the probability I will need another procedure in the next five years?"

   In high-SYNTAX disease, the five-year repeat revascularisation rate after stenting is substantially higher than after bypass. Ask for the number. A cardiologist who says "it depends" without giving you a range is not giving you the information you need to make a decision.

4. 4

   "Am I diabetic — and if so, have you factored the FREEDOM trial findings into this recommendation?"

   Diabetics with multi-vessel disease have a Class I guideline recommendation for bypass surgery. If you are diabetic and being offered stenting for multi-vessel disease, ask this question directly. The answer should explain why your case is an exception to the guideline recommendation.

5. 5

   "What would you recommend for your own family member with this angiogram?"

   It is a blunt question. It cuts through the clinical language. The answer — and the hesitation before it — tells you something that no guideline reference can. A good physician answers this without difficulty.

Getting a Second Opinion From India Before You Decide

---

You do not have to be in India to get a second opinion from an Indian cardiac surgeon. You need only your angiogram — the DICOM files or even good-quality photographs of the printed images — and your report.

GAF Healthcare forwards angiograms to the cardiac surgical team at Fortis Escorts Heart Institute or Medanta The Medicity. The surgeon reviews the imaging, calculates or confirms the SYNTAX score, and provides a written assessment of whether bypass or stenting is recommended for your specific anatomy. This assessment comes back within 48 to 72 hours.

The value is not that the Indian opinion is always different. Sometimes it confirms what you have already been told. But having a second opinion from a surgeon who has performed 2,000+ bypass surgeries — someone with no financial stake in whether you have a stent or surgery, and no relationship with the cardiologist who recommended your current plan — gives you a basis for a genuinely informed decision that you would not otherwise have.

If the second opinion agrees with your local cardiologist, you proceed with confidence. If it differs, you now have a specific clinical disagreement to investigate rather than a vague anxiety about whether the right decision is being made.

Sources: Serruys PW et al. SYNTAX Trial, NEJM 2009 · Mohr FW et al. SYNTAX 5-year follow-up, Lancet 2013 · Farkouh ME et al. FREEDOM Trial, NEJM 2012 · Stone GW et al. EXCEL Trial, NEJM 2016 · Mäkikallio T et al. NOBLE Trial, Lancet 2016 · 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization · ESC/EACTS Guidelines on Myocardial Revascularization 2023 · GAF Healthcare Hospital Review Database 2026